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ABSTRACT 
International Journal of Exercise Science 6(2) : 91-97, 2013. L-Arginine Alpha-
Ketoglutarate (AAKG) is purported to stimulate the release of nitric oxide, and is suggested to 
facilitate muscular performance by increasing blood flow and increase oxygen and nutrient 
delivery to the working muscle. However, the ergogenic benefit of AAKG during resistance 
exercise has not been established. Therefore the purpose of this study was to investigate the 
effects of acute AAKG ingestion in active ROTC Cadets on measures of one-repetition maximal 
strength (1RM) and muscular endurance. Nineteen apparently healthy males ingested either 
AAKG (3 g) or a placebo 45 minutes prior to resistance testing in a randomized, double-blind 
crossover design. Initially, blood lactate (BLA) was obtained followed by 1RM testing on the 
barbell bench press and leg press. Upon determination of 1RM, participants completed 
repetitions to failure at 60% of 1RM. Blood lactate measures were immediately taken following 
the final repetition. Analysis revealed no significant differences between the conditions for bench 
press 1RM. Additionally, there were no differences between conditions for 1RM leg press, or for 
number of repetitions performed for the bench press or leg press. Blood lactate values did 
increase significantly from baseline to post-bench press in both the AAKG (t33 = 7.56, p < 0.01) 
and placebo conditions (t33 = 8.45, p < 0.01). Further, BLA lactate levels were also significantly 
greater post leg-press in the AAKG (t33 = 9.23, p < 0.01) and placebo (t33 = 8.10, p < 0.01). The 
results indicate that acute AAKG supplementation provides no ergogenic benefit in this study. 
 




Over the past decade dietary supplements 
containing L-arginine have become very 
popular among resistance-trained athletes. 
This semi-essential amino acid is intended 
to increase strength, power, and recovery 
from intense muscular exercise (1). L-
arginine is used by all cells and plays a role 
in numerous physiological functions such 
as protein synthesis, synthesis of other 
amino acids, detoxification of ammonia, 
and may readily be converted α-
ketoglutarate (AKG) for ATP production (1, 
3). However, the purported ergogenic 
benefits of L-arginine probably stem from 
its (1) role in the synthesis of creatine; (2) 
contribution in the release of growth 
hormone and/or (3) function as a precursor 
in the biosynthesis of nitric oxide (NO) (4).  
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It is the latter that has gotten much of the 
attention as supplements containing L-
arginine are often advertised as “nitric 
oxide stimulators” (NO stimulators). There 
is a supportive rationale for such claims as 
NO can be produced from L-arginine via 
the enzyme NO synthase (1). NO produces 
a potent vasodilatory effect on blood 
vessels thereby possibly improving muscle 
blood flow during resistance training, thus 
allowing a greater delivery of fuel 
substrates and removal of lactate and 
ammonia (4). Conversely, there is still no 
clear evidence to conclude L-arginine’s role 
as a NO stimulator that augments 
resistance exercise performance in healthy 
individuals (1).  
 
Only a few studies have investigated the 
effects of L-arginine on resistance training 
performance. Chronic L-arginine 
supplementation has produced mixed 
results with some studies observing 
benefits in anaerobic power (3), muscular 
strength (3, 5, 14), and muscular endurance 
(15) while others have found no effect on 
these same performance variables (7, 8). 
Stevens et al. (14) used 13 participants to 
assess the acute responses of L-arginine 
ingestion. L-arginine or a placebo (sucrose) 
was isocalorically administered at 45, 30 
and 10 min before exercise using an 
isokinetic dynamometer. When compared 
with placebo, total work and peak torque 
were significantly greater while fatigue 
index was increased after consuming L-
arginine. Additionally, Villaverde et al. (15) 
reported observing decreased muscular 
fatigue evaluated by isokinetic 
dynamometer following 15 days of oral L-
arginine supplementation (3g/day). In 
contrast, Greer and Jones (8) used a double 
blind, cross-over design to investigate the 
acute effects of L-arginine α-ketoglutarate 
(AAKG) supplementation on muscular 
endurance and blood pressure responses. 
Twelve resistance-trained participants 
consumed 3,700 mg of either AAKG or 
placebo (maltodextrin) at two intervals (4 
hr and 30 min) prior to completion of chin-
ups, reverse chin-ups and push-ups to 
exhaustion. Blood pressure (BP) responses 
were monitored throughout each trial 
session. Results revealed that AAKG 
provided no ergogenic benefit during the 
muscular endurance tests and no 
differences were observed in BP across 
trials.  
 
To the authors knowledge, no investigation 
has explored the acute ingestion of AAKG 
during a bout of weight training; therefore, 
the purpose of this study was to investigate 
the acute ergogenic potential of AAKG on 
one-repetition maximum (1RM) strength 
and muscular endurance, as well as its’ 
impact on blood lactate (BLA) values in 





Nineteen apparently healthy, male ROTC 
Cadets volunteered for this investigation. 
Participants reported being free of any 
medical conditions, which would hinder 
their ability to perform the exercise 
protocol. Additionally, the cadets self-
reported not using any anabolic or 
metabolic supplements within the previous 
month. All participants gave their informed 
consent and completed a health history 
questionnaire before participating in the 
study. All experimental procedures were 
approved by Institutional Review Board at 
Mississippi State University.  Demographic 
data are described in Table 1. 
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Table 1. Subject demographic information. All data 
presented as mean ± standard deviation (SD). 
N = 19 Mean ± SD 
Age 19.42 ± 1.26 
Height (cm) 176.06 ± 7.08 
Weight (kg) 79.24 ± 10.57 
Body Fat % 15.17 ± 4.85 
 
Protocol 
Experimental Approach to the Problem: 
Participants reported to the Exercise 
Physiology Laboratory at the same time of 
day for each of the three testing sessions. 
Each session was separated by 7 days. The 
first session was used to collect the 
participants’ anthropometric data and serve 
as a familiarization session for the testing 
protocol. Participants were then randomly 
assigned a treatment session of either 
AAKG or placebo.  Treatments were 
administered in a counterbalanced, double-
blind manner, as neither investigators nor 
participants were aware of treatment order. 




Figure 1. Progression of the experimental protocol 
across time. 
 
Monitoring of Exercise and Dietary Status: 
Resistance trained participants were 
instructed to refrain from resistance 
training 48 h preceding testing and all 
participants were asked to avoid any 
strenuous activity 24 h prior to testing. 
Also, a 24 h dietary and exercise recall was 
completed before each trial, and 
participants were encouraged to follow the 
same nutritional intake preceding each 
session. Participants were also asked to 
abstain from taking any supplements, 
caffeine, or energy drinks during the 
investigation, as well as to refrain from 
alcohol intake, and medication during the 
48 h period preceding testing. 
 
Supplementation Schedule: AAKG 
(Healthwatchers DE Inc., Bohemia, NY) or a 
placebo consisting of microcrystalline 
cellulose (Apotheca Inc., Woodbine, IA) 
was provided to participants to be ingested 
45 min pre-exercise with 300 ml of water. 
The placebo was similar in color, size, and 
texture to the supplement. The selected 
dose for this investigation was based on a 
review of prior research in this area (16) 
and amounts recommended by many 
currently available AAKG supplements. 
One week later, participants reported to the 
laboratory to complete the last session. 
 
Blood Collection: A single-use lancet 
device was used to puncture the skin just 
off the center of the finger pad. The first 
flow of blood was wiped away, and then 
approximately 5µL (2mm) of blood was 
loaded on the lactate strip and immediately 
analyzed using the Lactate Pro Analyzer 
(LT 1710, ARKRAY Inc., Japan).  Blood 
samples were obtained pre-exercise and 
immediately following both the upper and 
lower body muscular endurance tests. 
 
Session 1: The preliminary session was 
conducted one week prior to the initiation 
of the two experimental sessions.  This 
initial session included a verbal explanation 
of the protocol, supplement restrictions 
(creatine, energy drinks, caffeine, etc.), and 
nutritional intake (24 h recall). During this 
preliminary session participants were also 
measured for height, body mass, and body 
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composition. Height was measured to the 
nearest 0.01 cm and body mass was 
measured in kilograms on a physicians’ 
balance beam scale (Healthometer 402EXP). 
Body composition was determined using 
the 3 site (abdomen, thigh, and chest) 
skinfold model described by Pollock and 
Wilmore (11). 
 
Session 2 and 3: Participants reported to 
the laboratory at their prescheduled time 
and prepared for testing. Upon arrival, 
participants were questioned about their 
compliance in regards to their activity level 
and completed their 24 h dietary recall for 
review by a trained evaluator. If a 
participant failed to meet the pretesting 
guidelines required for participation in that 
day’s protocol the session was rescheduled. 
All participants completed their scheduled 
sessions.  
 
Following the evaluator’s review and 
approval of the compliance guidelines, 
participants’ ingested either the AAKG 
supplement or placebo and then rested 
quietly for 40 min. At the conclusion of rest 
period, a measurement of BLA was 
collected prior to warm-up. Participants 
then warmed up on an upright stationary 
bike at a pace of 60 – 70 RPM for 5 min. 
Next, participants performed a 2-3 warm-
up sets of 10-12 repetitions using a load of 
61 kg on a standard barbell bench press 
(Magnum D78, Milwaukee, Wisconsin). 
Three minutes of rest time was allotted 
between each set. One-repetition maximum 
was determined according to the methods 
of Earle and Baechle (2). Each participant’s 
1RM was determined in 3-5 sets. 
 
Immediately following 1RM, 60% of the 
1RM was placed on the bar, and 
participants were allowed to rest for 5 
minutes, and then performed as many 
bench press repetitions as possible until 
failure occurred. Failure for the bench press 
in this study was defined as the inability to 
complete a repetition without assistance. 
Measurement of BLA was taken within 5 s 
of muscular failure.  
 
After a 5 min recovery period, participants 
began a warm-up on a Cybex 45° plate 
loaded leg press (Cybex Inc., Medway, MA) 
at a load of 82 kg for 12-15 repetitions, 
following the identical warm-up protocol 
used during the bench press. Once again, 
immediately following 1RM determination, 
60% of the 1RM was placed on the leg 
press, and participants were again allowed 
to recover for five minutes. The participants 
then performed as many leg press 
repetitions as possible until muscular 
failure occurred. Once again, BLA 
measurements were obtained within 5 s of 
termination of the leg press. 
 
Statistical Analysis 
Data analyses were performed using SPSS 
(v 18.0). Paired t-tests were performed to 
assess differences in performance measures 
(1RM, repetitions performed, total load) 
between conditions. Finally, BLA levels 
were examined utilizing repeated measures 
ANOVA to examine the differences in 
lactate changes from baseline to post-
muscular endurance assessment between 
conditions. Significant interactions were 
further analyzed utilizing one-way 
ANOVA and paired t-tests with Bonferroni 




All 19 ROTC Cadets who initially 
volunteered completed the testing 
procedures. There was no order effects 
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observed between the 2 conditions. 
Performance variables for both the bench 
press and leg press revealed no differences 
between the AAKG and placebo condition 
for 1RM (Figure 2a), number of repetitions 
performed (Figure 2b), or total volume of 
work performed (Figure 2c). 
 
 
Figure 2. Results for (a) 1RM, (b) repetitions 
performed, and (c) total load between the AAKG 
and placebo conditions. No differences between the 
two conditions were seen for any of the variables. 
 
Repeated measures ANOVA for BLA 
revealed no interaction or main effects for 
condition; however, a significant main 
effect for time was revealed (F2, 58 = 101.13, 
p < 0.01).  Blood lactate values (Figure 3) 
did increase significantly from baseline to 
post-bench press in both the AAKG (t33 = 
7.56, p < 0.01) and placebo conditions (t33 = 
8.45, p < 0.01) across time. Further, BLA 
levels were also significantly greater post 
leg-press in the AAKG (t33 = 9.23, p < 0.01) 




Figure 3. Blood lactate values after muscular 
endurance testing for the two conditions. Blood 
lactate increased significantly across time in both 
conditions (#p < 0.01), however there were no 
differences between values after upper-body (UB) or 




The major findings of this study were that 
acute ingestion of an AAKG supplement 
had no effect on muscular strength, 
endurance, or BLA concentration during 
resistance exercise in ROTC Cadets.  These 
findings serve to support previous work by 
Fricke (7) and Greer (8) that demonstrated 
no ergogenic benefits with L-arginine 
ingestion.  
The lack of ergogenic benefits may indicate 
that chronic use of L-arginine 
supplementation may be necessary for 
improved muscular performance. NO has 
been shown to reduce contractile force in 
mammalian skeletal muscle, thus a single 
dose may be inadequate to achieve acute 
changes in 1RM strength (13). Campbell et 
al. (3) did observe increased 1RM bench 
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press strength in well-trained participants 
after 8 weeks of AAKG supplementation 
(12 g per day). Interestingly, improvements 
in strength performance weren’t 
accompanied by muscle hypertrophy or 
changes in body composition even though 
participants lifted 4 days per week. An 
investigation by Elam and colleagues (5) 
reported increases in overall strength and 
lean body mass after 5 weeks of L-arginine 
and ornithine supplementation (5). 
Regrettably, this study used a posttest-only 
design, so the groups’ initial strength and 
lean muscle mass values may have differed.  
 
Similar to Greer and Jones (8), in this study 
AAKG supplementation provided no 
ergogenic benefit during upper or lower 
body muscular endurance testing.  
Furthermore, the authors speculated that 
AAKG supplementation may actually be 
counterproductive to muscular endurance 
performance by NO stimulated blood flow 
to the exercising muscle, thereby limiting a 
full range of motion for certain exercises.  
 
Surprisingly, no differences were observed 
in BLA concentration with AAKG 
supplementation during muscular 
endurance testing. If L-arginine leads to 
vasodilatation of blood vessels via NO 
production, one might assume BLA 
concentration would have been reduced 
with AAKG use. There is some recent 
evidence to suggest acute L-arginine 
supplementation doesn’t augment muscle 
blood flow during resistance training as 
much as first hypothesized (6, 12).   
 
There are also general limitations with this 
study. First, L-arginine and NO production 
were not measured in the blood stream, 
thereby limiting our ability to measure oral 
AAKG efficacy. Secondly, an acute dose of 
AAKG may not be sufficient to facilitate an 
ergogenic effect in normal healthy 
individuals (10). Liu et al. (9) reported no 
significant difference in plasma NO2 and 
NO3 concentrations after orally 
supplementing ten healthy male athletes 
with 3000 mg of L-arginine or placebo for 3 
days. Finally, the difference in 
methodology between this study and prior 
research does suggest that future studies 
should focus on combining repeated bouts 
of strength training exercises with a longer 
(> 10 days) AAKG loading phase.     
 
In conclusion, acute AAKG 
supplementation provided no ergogenic 
benefit in this study. Future acute and 
chronic studies on L-arginine are needed to 
further elucidate the underlying 
mechanisms of action in conjunction with 
measurements of resistance training 
performance. This would provide a much 
better understanding of the ergogenic 
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